Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal mometasone for childhood sleep disordered breathing
ACTRN12618000448246Phase 3Recruiting
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mometasone in sleep disordered breathing (SDB) (2 arms), sponsored by Murdoch Children's Research Institute. Primary endpoint: Resolution of sleep disordered breathing symptoms. Started Jun 2018; status: recruiting.
02
Drugs
mometasone
03
Conditions
sleep disordered breathing (SDB)
Beyond the preview
Go deeper on ACTRN12618000448246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000448246.